EXP PARASITOL 润色咨询

EXPERIMENTAL PARASITOLOGY

出版年份：1951 年文章数：2900 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：3.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1090459, encodeId=cbde10904596f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090460, encodeId=54ac1090460a9, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945427, encodeId=508194542e69, content=偏重的研究方向：抗寄生虫药物研发<br>经验分享：投稿至今一年，返修都接近半年了，还是under review，无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Thu Mar 04 13:58:49 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946882, encodeId=3aa09468829f, content=审稿速度:6.0<br>偏重的研究方向：抗寄生虫药物研发<br>经验分享：求助Experimental Parasitology的参考文献style ，求大神相助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Tue Mar 09 19:26:18 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832394, encodeId=12f78323949b, content=审稿速度:1.0<br>经验分享：修了三次，很负责，比较专业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ed45414080, createdName=ms9537892490195010, createdTime=Wed Jun 15 20:58:43 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523739, encodeId=114f523e393c, content=杂志很负责，修了三次，很庆幸最终接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c21653352, createdName=zenmole, createdTime=Wed Jun 15 20:52:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517380, encodeId=0aab51e380f1, content=第一次投这个杂志，没想到这么慢，初审两个月零三周后，直接拒稿，文稿也没指出什么不当，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1701667349, createdName=金刚007, createdTime=Sun Dec 06 09:49:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829718, encodeId=a2bb829e183a, content=审稿速度:4.0<br>经验分享：该期刊在医学和兽医学寄生虫学领域知名度较高，同行评阅遍布世界各地，比较国际化。需要改进的地方是审稿过程有点繁琐，周期稍长！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Thu Jul 03 09:43:32 CST 2014, time=2014-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501622, encodeId=136750162260, content=审稿速度:2.0<br>经验分享：一审一个多月，二审被一个审稿人耽误了，托了我5个月。终于接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 07 14:13:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501221, encodeId=7125501221c6, content=投一次一月被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 20 15:52:00 CST 2014, time=2014-02-20, status=1, ipAttribution=)]
    2021-12-29 msSSSSSD

    推荐同行评议时需要注意哪些情况？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1090459, encodeId=cbde10904596f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090460, encodeId=54ac1090460a9, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945427, encodeId=508194542e69, content=偏重的研究方向：抗寄生虫药物研发<br>经验分享：投稿至今一年，返修都接近半年了，还是under review，无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Thu Mar 04 13:58:49 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946882, encodeId=3aa09468829f, content=审稿速度:6.0<br>偏重的研究方向：抗寄生虫药物研发<br>经验分享：求助Experimental Parasitology的参考文献style ，求大神相助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Tue Mar 09 19:26:18 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832394, encodeId=12f78323949b, content=审稿速度:1.0<br>经验分享：修了三次，很负责，比较专业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ed45414080, createdName=ms9537892490195010, createdTime=Wed Jun 15 20:58:43 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523739, encodeId=114f523e393c, content=杂志很负责，修了三次，很庆幸最终接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c21653352, createdName=zenmole, createdTime=Wed Jun 15 20:52:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517380, encodeId=0aab51e380f1, content=第一次投这个杂志，没想到这么慢，初审两个月零三周后，直接拒稿，文稿也没指出什么不当，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1701667349, createdName=金刚007, createdTime=Sun Dec 06 09:49:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829718, encodeId=a2bb829e183a, content=审稿速度:4.0<br>经验分享：该期刊在医学和兽医学寄生虫学领域知名度较高，同行评阅遍布世界各地，比较国际化。需要改进的地方是审稿过程有点繁琐，周期稍长！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Thu Jul 03 09:43:32 CST 2014, time=2014-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501622, encodeId=136750162260, content=审稿速度:2.0<br>经验分享：一审一个多月，二审被一个审稿人耽误了，托了我5个月。终于接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 07 14:13:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501221, encodeId=7125501221c6, content=投一次一月被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 20 15:52:00 CST 2014, time=2014-02-20, status=1, ipAttribution=)]
    2021-12-29 msSSSSSD

    什么是correspondingauthor/通讯作者？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1090459, encodeId=cbde10904596f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090460, encodeId=54ac1090460a9, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945427, encodeId=508194542e69, content=偏重的研究方向：抗寄生虫药物研发<br>经验分享：投稿至今一年，返修都接近半年了，还是under review，无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Thu Mar 04 13:58:49 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946882, encodeId=3aa09468829f, content=审稿速度:6.0<br>偏重的研究方向：抗寄生虫药物研发<br>经验分享：求助Experimental Parasitology的参考文献style ，求大神相助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Tue Mar 09 19:26:18 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832394, encodeId=12f78323949b, content=审稿速度:1.0<br>经验分享：修了三次，很负责，比较专业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ed45414080, createdName=ms9537892490195010, createdTime=Wed Jun 15 20:58:43 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523739, encodeId=114f523e393c, content=杂志很负责，修了三次，很庆幸最终接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c21653352, createdName=zenmole, createdTime=Wed Jun 15 20:52:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517380, encodeId=0aab51e380f1, content=第一次投这个杂志，没想到这么慢，初审两个月零三周后，直接拒稿，文稿也没指出什么不当，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1701667349, createdName=金刚007, createdTime=Sun Dec 06 09:49:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829718, encodeId=a2bb829e183a, content=审稿速度:4.0<br>经验分享：该期刊在医学和兽医学寄生虫学领域知名度较高，同行评阅遍布世界各地，比较国际化。需要改进的地方是审稿过程有点繁琐，周期稍长！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Thu Jul 03 09:43:32 CST 2014, time=2014-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501622, encodeId=136750162260, content=审稿速度:2.0<br>经验分享：一审一个多月，二审被一个审稿人耽误了，托了我5个月。终于接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 07 14:13:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501221, encodeId=7125501221c6, content=投一次一月被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 20 15:52:00 CST 2014, time=2014-02-20, status=1, ipAttribution=)]
    2021-03-04 carolloo

    偏重的研究方向：抗寄生虫药物研发
    经验分享：投稿至今一年，返修都接近半年了，还是under review，无语了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1090459, encodeId=cbde10904596f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090460, encodeId=54ac1090460a9, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945427, encodeId=508194542e69, content=偏重的研究方向：抗寄生虫药物研发<br>经验分享：投稿至今一年，返修都接近半年了，还是under review，无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Thu Mar 04 13:58:49 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946882, encodeId=3aa09468829f, content=审稿速度:6.0<br>偏重的研究方向：抗寄生虫药物研发<br>经验分享：求助Experimental Parasitology的参考文献style ，求大神相助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Tue Mar 09 19:26:18 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832394, encodeId=12f78323949b, content=审稿速度:1.0<br>经验分享：修了三次，很负责，比较专业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ed45414080, createdName=ms9537892490195010, createdTime=Wed Jun 15 20:58:43 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523739, encodeId=114f523e393c, content=杂志很负责，修了三次，很庆幸最终接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c21653352, createdName=zenmole, createdTime=Wed Jun 15 20:52:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517380, encodeId=0aab51e380f1, content=第一次投这个杂志，没想到这么慢，初审两个月零三周后，直接拒稿，文稿也没指出什么不当，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1701667349, createdName=金刚007, createdTime=Sun Dec 06 09:49:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829718, encodeId=a2bb829e183a, content=审稿速度:4.0<br>经验分享：该期刊在医学和兽医学寄生虫学领域知名度较高，同行评阅遍布世界各地，比较国际化。需要改进的地方是审稿过程有点繁琐，周期稍长！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Thu Jul 03 09:43:32 CST 2014, time=2014-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501622, encodeId=136750162260, content=审稿速度:2.0<br>经验分享：一审一个多月，二审被一个审稿人耽误了，托了我5个月。终于接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 07 14:13:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501221, encodeId=7125501221c6, content=投一次一月被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 20 15:52:00 CST 2014, time=2014-02-20, status=1, ipAttribution=)]
    2021-03-09 carolloo

    审稿速度:6.0
    偏重的研究方向：抗寄生虫药物研发
    经验分享：求助Experimental Parasitology的参考文献style ，求大神相助

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1090459, encodeId=cbde10904596f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090460, encodeId=54ac1090460a9, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945427, encodeId=508194542e69, content=偏重的研究方向：抗寄生虫药物研发<br>经验分享：投稿至今一年，返修都接近半年了，还是under review，无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Thu Mar 04 13:58:49 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946882, encodeId=3aa09468829f, content=审稿速度:6.0<br>偏重的研究方向：抗寄生虫药物研发<br>经验分享：求助Experimental Parasitology的参考文献style ，求大神相助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Tue Mar 09 19:26:18 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832394, encodeId=12f78323949b, content=审稿速度:1.0<br>经验分享：修了三次，很负责，比较专业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ed45414080, createdName=ms9537892490195010, createdTime=Wed Jun 15 20:58:43 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523739, encodeId=114f523e393c, content=杂志很负责，修了三次，很庆幸最终接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c21653352, createdName=zenmole, createdTime=Wed Jun 15 20:52:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517380, encodeId=0aab51e380f1, content=第一次投这个杂志，没想到这么慢，初审两个月零三周后，直接拒稿，文稿也没指出什么不当，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1701667349, createdName=金刚007, createdTime=Sun Dec 06 09:49:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829718, encodeId=a2bb829e183a, content=审稿速度:4.0<br>经验分享：该期刊在医学和兽医学寄生虫学领域知名度较高，同行评阅遍布世界各地，比较国际化。需要改进的地方是审稿过程有点繁琐，周期稍长！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Thu Jul 03 09:43:32 CST 2014, time=2014-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501622, encodeId=136750162260, content=审稿速度:2.0<br>经验分享：一审一个多月，二审被一个审稿人耽误了，托了我5个月。终于接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 07 14:13:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501221, encodeId=7125501221c6, content=投一次一月被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 20 15:52:00 CST 2014, time=2014-02-20, status=1, ipAttribution=)]
    2016-06-15 ms9537892490195010

    审稿速度:1.0
    经验分享：修了三次，很负责，比较专业

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1090459, encodeId=cbde10904596f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090460, encodeId=54ac1090460a9, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945427, encodeId=508194542e69, content=偏重的研究方向：抗寄生虫药物研发<br>经验分享：投稿至今一年，返修都接近半年了，还是under review，无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Thu Mar 04 13:58:49 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946882, encodeId=3aa09468829f, content=审稿速度:6.0<br>偏重的研究方向：抗寄生虫药物研发<br>经验分享：求助Experimental Parasitology的参考文献style ，求大神相助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Tue Mar 09 19:26:18 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832394, encodeId=12f78323949b, content=审稿速度:1.0<br>经验分享：修了三次，很负责，比较专业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ed45414080, createdName=ms9537892490195010, createdTime=Wed Jun 15 20:58:43 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523739, encodeId=114f523e393c, content=杂志很负责，修了三次，很庆幸最终接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c21653352, createdName=zenmole, createdTime=Wed Jun 15 20:52:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517380, encodeId=0aab51e380f1, content=第一次投这个杂志，没想到这么慢，初审两个月零三周后，直接拒稿，文稿也没指出什么不当，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1701667349, createdName=金刚007, createdTime=Sun Dec 06 09:49:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829718, encodeId=a2bb829e183a, content=审稿速度:4.0<br>经验分享：该期刊在医学和兽医学寄生虫学领域知名度较高，同行评阅遍布世界各地，比较国际化。需要改进的地方是审稿过程有点繁琐，周期稍长！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Thu Jul 03 09:43:32 CST 2014, time=2014-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501622, encodeId=136750162260, content=审稿速度:2.0<br>经验分享：一审一个多月，二审被一个审稿人耽误了，托了我5个月。终于接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 07 14:13:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501221, encodeId=7125501221c6, content=投一次一月被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 20 15:52:00 CST 2014, time=2014-02-20, status=1, ipAttribution=)]
    2016-06-15 zenmole

    杂志很负责，修了三次，很庆幸最终接收了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1090459, encodeId=cbde10904596f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090460, encodeId=54ac1090460a9, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945427, encodeId=508194542e69, content=偏重的研究方向：抗寄生虫药物研发<br>经验分享：投稿至今一年，返修都接近半年了，还是under review，无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Thu Mar 04 13:58:49 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946882, encodeId=3aa09468829f, content=审稿速度:6.0<br>偏重的研究方向：抗寄生虫药物研发<br>经验分享：求助Experimental Parasitology的参考文献style ，求大神相助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Tue Mar 09 19:26:18 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832394, encodeId=12f78323949b, content=审稿速度:1.0<br>经验分享：修了三次，很负责，比较专业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ed45414080, createdName=ms9537892490195010, createdTime=Wed Jun 15 20:58:43 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523739, encodeId=114f523e393c, content=杂志很负责，修了三次，很庆幸最终接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c21653352, createdName=zenmole, createdTime=Wed Jun 15 20:52:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517380, encodeId=0aab51e380f1, content=第一次投这个杂志，没想到这么慢，初审两个月零三周后，直接拒稿，文稿也没指出什么不当，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1701667349, createdName=金刚007, createdTime=Sun Dec 06 09:49:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829718, encodeId=a2bb829e183a, content=审稿速度:4.0<br>经验分享：该期刊在医学和兽医学寄生虫学领域知名度较高，同行评阅遍布世界各地，比较国际化。需要改进的地方是审稿过程有点繁琐，周期稍长！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Thu Jul 03 09:43:32 CST 2014, time=2014-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501622, encodeId=136750162260, content=审稿速度:2.0<br>经验分享：一审一个多月，二审被一个审稿人耽误了，托了我5个月。终于接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 07 14:13:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501221, encodeId=7125501221c6, content=投一次一月被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 20 15:52:00 CST 2014, time=2014-02-20, status=1, ipAttribution=)]
    2015-12-06 金刚007

    第一次投这个杂志，没想到这么慢，初审两个月零三周后，直接拒稿，文稿也没指出什么不当，垃圾。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1090459, encodeId=cbde10904596f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090460, encodeId=54ac1090460a9, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945427, encodeId=508194542e69, content=偏重的研究方向：抗寄生虫药物研发<br>经验分享：投稿至今一年，返修都接近半年了，还是under review，无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Thu Mar 04 13:58:49 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946882, encodeId=3aa09468829f, content=审稿速度:6.0<br>偏重的研究方向：抗寄生虫药物研发<br>经验分享：求助Experimental Parasitology的参考文献style ，求大神相助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Tue Mar 09 19:26:18 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832394, encodeId=12f78323949b, content=审稿速度:1.0<br>经验分享：修了三次，很负责，比较专业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ed45414080, createdName=ms9537892490195010, createdTime=Wed Jun 15 20:58:43 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523739, encodeId=114f523e393c, content=杂志很负责，修了三次，很庆幸最终接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c21653352, createdName=zenmole, createdTime=Wed Jun 15 20:52:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517380, encodeId=0aab51e380f1, content=第一次投这个杂志，没想到这么慢，初审两个月零三周后，直接拒稿，文稿也没指出什么不当，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1701667349, createdName=金刚007, createdTime=Sun Dec 06 09:49:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829718, encodeId=a2bb829e183a, content=审稿速度:4.0<br>经验分享：该期刊在医学和兽医学寄生虫学领域知名度较高，同行评阅遍布世界各地，比较国际化。需要改进的地方是审稿过程有点繁琐，周期稍长！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Thu Jul 03 09:43:32 CST 2014, time=2014-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501622, encodeId=136750162260, content=审稿速度:2.0<br>经验分享：一审一个多月，二审被一个审稿人耽误了，托了我5个月。终于接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 07 14:13:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501221, encodeId=7125501221c6, content=投一次一月被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 20 15:52:00 CST 2014, time=2014-02-20, status=1, ipAttribution=)]
    2014-07-03 ms5469518383470847

    审稿速度:4.0
    经验分享：该期刊在医学和兽医学寄生虫学领域知名度较高，同行评阅遍布世界各地，比较国际化。需要改进的地方是审稿过程有点繁琐，周期稍长！

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1090459, encodeId=cbde10904596f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090460, encodeId=54ac1090460a9, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945427, encodeId=508194542e69, content=偏重的研究方向：抗寄生虫药物研发<br>经验分享：投稿至今一年，返修都接近半年了，还是under review，无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Thu Mar 04 13:58:49 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946882, encodeId=3aa09468829f, content=审稿速度:6.0<br>偏重的研究方向：抗寄生虫药物研发<br>经验分享：求助Experimental Parasitology的参考文献style ，求大神相助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Tue Mar 09 19:26:18 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832394, encodeId=12f78323949b, content=审稿速度:1.0<br>经验分享：修了三次，很负责，比较专业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ed45414080, createdName=ms9537892490195010, createdTime=Wed Jun 15 20:58:43 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523739, encodeId=114f523e393c, content=杂志很负责，修了三次，很庆幸最终接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c21653352, createdName=zenmole, createdTime=Wed Jun 15 20:52:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517380, encodeId=0aab51e380f1, content=第一次投这个杂志，没想到这么慢，初审两个月零三周后，直接拒稿，文稿也没指出什么不当，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1701667349, createdName=金刚007, createdTime=Sun Dec 06 09:49:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829718, encodeId=a2bb829e183a, content=审稿速度:4.0<br>经验分享：该期刊在医学和兽医学寄生虫学领域知名度较高，同行评阅遍布世界各地，比较国际化。需要改进的地方是审稿过程有点繁琐，周期稍长！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Thu Jul 03 09:43:32 CST 2014, time=2014-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501622, encodeId=136750162260, content=审稿速度:2.0<br>经验分享：一审一个多月，二审被一个审稿人耽误了，托了我5个月。终于接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 07 14:13:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501221, encodeId=7125501221c6, content=投一次一月被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 20 15:52:00 CST 2014, time=2014-02-20, status=1, ipAttribution=)]
    2014-03-07 匿名用户

    审稿速度:2.0
    经验分享：一审一个多月，二审被一个审稿人耽误了，托了我5个月。终于接受。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1090459, encodeId=cbde10904596f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090460, encodeId=54ac1090460a9, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945427, encodeId=508194542e69, content=偏重的研究方向：抗寄生虫药物研发<br>经验分享：投稿至今一年，返修都接近半年了，还是under review，无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Thu Mar 04 13:58:49 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946882, encodeId=3aa09468829f, content=审稿速度:6.0<br>偏重的研究方向：抗寄生虫药物研发<br>经验分享：求助Experimental Parasitology的参考文献style ，求大神相助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=439e2216801, createdName=carolloo, createdTime=Tue Mar 09 19:26:18 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832394, encodeId=12f78323949b, content=审稿速度:1.0<br>经验分享：修了三次，很负责，比较专业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ed45414080, createdName=ms9537892490195010, createdTime=Wed Jun 15 20:58:43 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523739, encodeId=114f523e393c, content=杂志很负责，修了三次，很庆幸最终接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c21653352, createdName=zenmole, createdTime=Wed Jun 15 20:52:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517380, encodeId=0aab51e380f1, content=第一次投这个杂志，没想到这么慢，初审两个月零三周后，直接拒稿，文稿也没指出什么不当，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1701667349, createdName=金刚007, createdTime=Sun Dec 06 09:49:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829718, encodeId=a2bb829e183a, content=审稿速度:4.0<br>经验分享：该期刊在医学和兽医学寄生虫学领域知名度较高，同行评阅遍布世界各地，比较国际化。需要改进的地方是审稿过程有点繁琐，周期稍长！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Thu Jul 03 09:43:32 CST 2014, time=2014-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501622, encodeId=136750162260, content=审稿速度:2.0<br>经验分享：一审一个多月，二审被一个审稿人耽误了，托了我5个月。终于接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 07 14:13:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501221, encodeId=7125501221c6, content=投一次一月被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 20 15:52:00 CST 2014, time=2014-02-20, status=1, ipAttribution=)]
    2014-02-20 匿名用户

    投一次一月被拒了

    0

共14条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分